SeQuent Scientific and Viyash Lifesciences announced a merger on Friday, aiming to establish a leadership position in the global animal health market. The companies stated that Viyash's operational strengths will greatly enhance the scale of the merged entity, improve its R&D capabilities, bolster its supply chain, and position it as a major player in the rapidly growing pharmaceutical markets.
Comments
Post a Comment